AzTrials
AzTrials

Alveolar Bone ResorptionNCT04955873

Ridge Preservation Using Xenogenic Bone Graft and Pre-hydrated Collagen Membrane

A study testing Treatment of the dental extraction socket using newly-released biomaterials and Treatment of the dental extraction socket using well-known biomaterials in people with Alveolar Bone Resorption and Edentulous Alveolar Ridge, run by Fondazione Bruno Kessler at 5 sites in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This pilot multicentric randomized controlled clinical trial is aimed at evaluating the composition of the new-formed tissue into the dental socket after 6 months from tooth extraction and the application of a combination of xenograft bone granules and collagen membrane. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Treatment of the dental extraction socket using newly-released biomaterials and Treatment of the dental extraction socket using well-known biomaterials
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
5 sitesItaly
Study dates
Aug 2021to 1 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • have at least one tooth (from the central incisor to the second permanent molar) to be extracted and replaced with an endosseous implant;
  • no need of a temporary prosthesis;
  • availability to participate to the follow-up;
  • sign the study informed consent and consent to data treatment;

Who cannot join

  • less than 20 years;
  • known allergy to collagen or bone graft material;
  • contraindications to implant therapy;
  • ongoing bisphosphonate-based therapy;
  • ongoing high-dose corticosteroid therapy;
  • relevant co-morbidities of the maxillary bones that interfere with bone remodeling (degenerative bone diseases, osteomyelitis at the extraction site or surrounding areas, subacute mandibular osteitis, local microvascular disorders);
Show all 10Show fewer
  • smoking;
  • pregnancy;
  • metabolic diseases (diabetes, hyperparathyroidism);
  • systemic bone diseases;

Trial locations and contacts

5 sites in 1 country.

Paolo Ghensi, DDS, PhD contact

+39 0461 282775

dr.ghensi@gmail.com

Francesco Tessarolo, PhD contact

+39 0461 282775

francesco.tessarolo@unitn.it

5 sites in 1 country

Italy5 sites, 5 recruiting
  • Studio Dentistico Associato Tomasi-Ghensi-Varotto

    Cembra, Trento, 38054

    Enrolling by invitation
  • Studio Dentistico Bressan Associati Di Bressan Eriberto - Bressan Giuseppe - Bressan Paolo

    Chions, Pordenone, 33083

    Eriberto Bressan, MD, Prof.

    Recruiting
  • Studio Odontoiatrico Maia Dentis

    Merano, Bolzano, 39012

    Antonio Bonaccorso, MD

    Teresa R Tripi, MD

    Recruiting
  • Studio Dentistico Donati Di Donati Andrea & Mauro

    Perugia, 06121

    Mauro Donati

    Recruiting
  • Studio Medico Dentistico Dott. Mandelli

    Pioltello, Milano, 20096

    Federico Mandelli, MD

    Recruiting

Other trials in Italy

About this study

Official title: Ridge Preservation With the Use of a Xenogenic Bone Graft Material (Symbios Xenograft Granules) and a Pre-hydrated Collagen Membrane Symbios Pre-hydrated Collagen Resorbable Membrane): A Pilot Multicenter Randomized Controlled Study

This pilot multicentric randomized controlled clinical trial is aimed at evaluating the composition of the new-formed tissue into the dental socket after 6 months from tooth extraction and the application of a combination of xenograft bone granules and collagen membrane. Extraction sites will be either grafted with Dentsply Symbios Xenograft Granules and covered with Dentsply Symbios pre-hydrated Collagen Resorbable Membrane or grafted with Geistlich Bio-Oss Collagen and covered with Geistlich Bio-Gide membrane. Results will be compared to spontaneous socket healing.

Read the detailed description

Rational

Socket preservation techniques are effective in mitigating the dimensional changes of the alveolar socket that spontaneously occur after tooth extraction (Avila-Ortiz G, et al. 2019). However, there is insufficient information regarding the type and quality of the newly formed tissue at the extraction site before implant positioning.

Study design

This study is a three-arm multicentric randomized trial that will evaluate the bone healing following ridge preservation of extraction sockets using two different combinations of commercially available xenograft bone granules and collagen membranes available in the market. Results will be compared to tissues obtained from spontaneous healing. A total of 45 participants (15 in each arm) is expected.

Study protocol

Patients, satisfying inclusion criteria and having signed study informed consent, will be randomly allocated to three study groups, receiving the following treatments at the time of tooth extraction:

  • Group A: grafting of postextraction socket with Dentsply Symbios Xenograft granules covered with Dentsply Symbios pre-hydrated Collagen Resorbable Membrane (Test - Group A)
  • Group B: grafting of postextraction socket with Geistlich Bio-Oss Collagen and covering with Geistlich Bio-Gide Collagen membrane (Active comparator - Group B)
  • Group C: no further treatment of the postextraction socket (spontaneous healing, Control - Group C) After 6 months from the extraction, radiographic examinations will be performed and the implant surgery will take place.

On the day of the surgery the width of keratinized mucosa at socked site will be registered. Then, following loco-regional anesthesia, a soft tissue sample of 3 mm in diameter will be obtained using a circular punch at the site intended to receive the implant. Subsequently, a flap will be elevated. Using a trephine drill a 3 mm in diameter block of hard tissue with a length of 5- 6 mm will be collected. The preparation of the implant site will be then carried out until the desired diameter and length are reached for the insertion of the corresponding implant. Torque at implant insertion will be registered.

Once the implant has been inserted, the healing abutment will be positioned and soft tissues will be sutured with single sutures. The prosthetic rehabilitation will be completed after osseointegration, approximately 3 months after the implant surgery.

Histological analysis of soft tissue and hard tissue biopsies

Tissue samples will be immediately fixed in formalin after collection. Histological analysis will be performed on formalin-fixed paraffin-embedded tissue sections, to determine the quantity and quality newly formed tissue and the remaining fraction of the implanted biomaterials.

More specifically, the collected tissue biopsies will be fixed in 4% buffered formalin, decalcified into ethylenediaminetetraacetic acid (EDTA) (if necessary), dehydrated and included in paraffin. Serial sections, including the central portion of the biopsy, will be prepared and colored in hematoxylin and eosin. Vascular structures will be identified by CD34 (Cluster of differentiation 34, hematopoietic progenitor cell antigen) antibody. Portions occupied by mineralized bone (lamellar bone, trabecular bone), osteoid (partially mineralized connective tissue matrix rich in collagen), bone marrow (adipocytes and vascular structures), fibrous tissue (unorganized collagen fibers, cells and vessels), biomaterial granules and residual tissue (unidentified tissue elements, preparation artifacts) will be characterized by morphometric measurements performed according to the protocol described by Lindhe et al. (Clin. Oral Impl. Res.2014;25:786-790). Soft tissues characterization will include the analysis of the structural composition of epithelial and connective tissues, the quantification of the amount micro-vessels in connective tissue, the definition of the inflammatory cell types, and the collagen tissue content according to protocols described in Tomasi et al. (J Clin Periodontol. 2016;43:816-24).

Data analysis and statistics

Data analysis will be aimed at detecting statistically significant differences in tissue composition between the group A in respect to the most appropriate of the two remaining groups (e.g. the percentage of bone tissue in the test group will be compared with that of control group C while the percentage of residual biomaterial six months after implantation will be compared with the active control B). Statistically significant differences with p<0.05 will be considered.

Data normality will be verified with the Shapiro-Wilk test. Outcome variables for each of three groups will be expressed by means of mean ± standard deviation for continuous variables with normal distribution, or by means of median and value at the 25th and 75th percentile for variables with non-normal distribution. Parametric or non-parametric statistical tests will then be applied to compare between groups, according to data normality.

Being tested
Treatment of the dental extraction socket using newly-released biomaterials, Treatment of the dental extraction socket using well-known biomaterials
Keywords
Ridge preservation, Xenograft, Collagen membrane, Socket preservation, Socket management, Biomaterial, Histomorphometry

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment of the dental extraction socket using newly-released biomaterialsDevice

    Treatment of the dental extraction socket with the combined use with the combined use of a newly-released xenogenic bone granules and a resorbable collagen membrane.

  • Treatment of the dental extraction socket using well-known biomaterialsDevice

    Treatment of the dental extraction socket with the combined use of a well-known xenogenic bone granules and a resorbable collagen membrane

Study groups in NCT04955873
Study groupRoleWhat they receive
Test - Group A - Dentsply biomaterialsExperimentalDental extraction socket treated with the combined use of the xenogenic bone granules "Dentsply Sirona Symbios Xenograft Granules" and the resorbable collagen membrane "Dentsply Sirona Symbios Collagen Membrane SR".
Receives: Device: Treatment of the dental extraction socket using newly-released biomaterials
Active comparator - Group B - Geistlich biomaterialsActive comparatorDental extraction socket treated with the combined use of the xenogenic bone granules "Geistlich Bio-oss Collagen" and the resorbable collagen membrane "Geistlich BioGide".
Receives: Device: Treatment of the dental extraction socket using well-known biomaterials
Control - Group C - Spontaneous healingNo interventionSpontaneous postextraction alveolar healing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Composition of new-formed hard tissue into the post-extractive socket

    Amount of mineralized bone, residual biomaterial, fibrous tissue

    Measured: Six months after surgery

  2. Composition of new-formed soft tissue over the post-extractive socket

    Amount of epithelial tissue, connective tissue, of neovascularization, inflammatory cells, residual collagenic biomaterial

    Measured: Six months after surgery

Secondary outcomes (2)
  1. Implant torque at insertion

    Dynamometric measurement of the insertion torque at implant placement

    Measured: Six months after surgery, at implant insertion.

  2. Width of keratinized mucosa

    Extension of keratinized mucosa in the bucco-lingual direction

    Measured: Six months after surgery, at implant insertion.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2021
  2. Study startAug 2021 (estimated)
  3. Primary completion1 Feb 2023 (estimated)
  4. Study completion1 Apr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04955873
Sponsor's protocol ID
I-BI-16-004
Status last verified
Aug 2021
First submitted
5 Jul 2021
Last updated
10 Aug 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Avila-Ortiz G, Chambrone L, Vignoletti F. Effect of alveolar ridge preservation interventions following tooth extraction: A systematic review and meta-analysis. J Clin Periodontol. 2019 Jun;46 Suppl 21:195-223. doi: 10.1111/jcpe.13057.

    PubMed 30623987
  • Lindhe J, Cecchinato D, Donati M, Tomasi C, Liljenberg B. Ridge preservation with the use of deproteinized bovine bone mineral. Clin Oral Implants Res. 2014 Jul;25(7):786-90. doi: 10.1111/clr.12170. Epub 2013 Apr 4.

    PubMed 23556467
  • Tomasi C, Tessarolo F, Caola I, Piccoli F, Wennstrom JL, Nollo G, Berglundh T. Early healing of peri-implant mucosa in man. J Clin Periodontol. 2016 Oct;43(10):816-24. doi: 10.1111/jcpe.12591. Epub 2016 Jul 28.

    PubMed 27329966

Questions about this trial

What is this clinical trial studying?

A study testing Treatment of the dental extraction socket using newly-released biomaterials and Treatment of the dental extraction socket using well-known biomaterials in people with Alveolar Bone Resorption and Edentulous Alveolar Ridge, run by Fondazione Bruno Kessler at 5 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paolo Ghensi, DDS, PhD (+39 0461 282775, dr.ghensi@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Composition of new-formed hard tissue into the post-extractive socket (time frame: Six months after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04955873, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in